Proactive Investors - Run By Investors For Investors

Tilray adds Howard Dean and others to newly formed international advisory board

On the list of members of the cannabis company's new advisory circle are the former US presidential candidate and Jaime Gama, Portugal's former minister of foreign affairs
empty board room
Tilray focuses on medical cannabis research and cultivation

Tilray (NASDAQ:TLRY) has formed an international advisory board to offer guidance to its executive team and board of directors.

The first members of the cannabis company’s new circle of advisers include:

  • Howard Dean, former US presidential candidate, six-term governor of Vermont, physician and former Democratic National Committee chairman
  • Michael Steele, the former Lieutenant Governor of Maryland
  • Lloyd Axworthy, the chair of the World Refugee Council
  • Jaime Gama, Portugal’s former Minister of Foreign Affairs
  • Alexander John Gosse Downer, Australia’s former Minister for Foreign Affairs
  • Donald McKinnon, New Zealand’s former Minister of Foreign Affairs and Trade
  • Maria Lorena Gutierrez Botero, Colombia’s former ambassador to Germany who also served as the country’s Minister of Commerce, Industry and Tourism
  • James O’Brien, a former senior advisor to the US Secretary of State and vice-chair of Albright Stonebridge Group
  • Lorna Marsden, a former Canadian Senator from Ontario

Tilray, which focuses on medical cannabis research, cultivation and distribution, is headquartered in Nanaimo, British Columbia.

The company's shares traded up 1.8% to hit $86 in US trading before the opening bell on Thursday.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full TLRY profile View Profile

Tilray Inc Timeline

Related Articles

cannabis flower
April 26 2019
The company's footprint continues to grow as it focuses on becoming a globally recognized house of brands with a broad portfolio of clients across North America
cannabis bud on tray
April 25 2019
Armed with a new partnership with Canada's largest pharmacy and an international cultivator, Flowr is aiming to provide medicinal and recreational consumers around the world with premium, high-quality cannabis
medicinal cannabis concept
January 30 2019
Zelda has released its December quarterly report confirming multiple trials are on track.
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use